WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study.
Abstract
Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
Abstract
Parasite load decrease during application of a safe and easily applied antileishmanial aminoglycoside cream.
Abstract